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SUMMARY
Two foot and mouth disease vaccines were submitted to the “C Index” efficiency test with six 
replicates each using four guinea pigs per viral dilution for titration. The values obtained, when 
transformed into quality of the vaccine, demonstrated that the same vaccine could be scored as 
“rejected regular”, “approved good” or “approved very good”, indicating that the random variation 
in the results may prevent a classification of the immunogen. To determine whether these variations 
are due to the small number of guinea pigs used, one vaccine was submitted to six replicates using 
five guinea pigs per viral dilution in the “C Index” test. Analyses of the results using 2 by 2, 3 by
3, 4 by 4 and 5 by 5 arrangements from the data corresponding to all possible combinations when 
5, 10, 20 ,25  or 30 guinea pigs were used per viral dilution demonstrated that the plus or minus (±) 
0.5 log10 variation with 95% confidence limits corresponds to 15 guinea pigs.
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INTRODUCTION
In countries in which foot and mouth disease (FMD) is 
endemic, the quality of each lot of FMD vaccine produced is 
determined by direct and indirect methods for immunogenicity 
control. The direct control methods of FMD vaccines in cattle 
present serious limitations o f precision and sensitivity, due to 
the impossibility of using an adequate number of sensitive 
animals and due to the high cost of these tests, a fact that 
prevents their application in the control of all vaccine lots 
needed for programs of disease control. Furthermore, the 
precision of the tests can only be improved with the use of a 
larger number o f anim als (FERNANDEZ et al.7, 1972; 
MOW AT et al.'4, 1973; GARLAND et al.’, 1977).
The indirect methods, when they present an appropriate 
relationship with direct methods, are the only ones which 
permit valuable and less costly routine procedures to determine 
the efficiency of vaccines against foot and mouth disease.
This paper describes experiments carried out in order to 
determine whether the number of guinea pigs per viral dilution 
used for titration affects the results of the C Index test, and to 
clarify the variations observed in the titrations when these 
tests are performed.
MATERIAL AND METHOD
Vaccines
Three lots o f commercial foot and mouth disease vaccines 
were tested. The following FMD virus (FMDV) strains were 
used for the preparation of the vaccine: 0 ,  Campos, Ay
Cruzeiro, A Venceslau and C3 Indaial. The viruses were grown 
in BHK^, cells (MACPHERSON; STOKER15, 1962) inacti­
vated with acetylethyleneimine (AEI) and containing alumi­
nium hydroxide and saponin as adjuvants. These vaccines 
had been previously tested for efficiency by the official labo­
ratory of the Ministry of Agriculture and Agrarian Reform, 
Brazil.
Challenge viruses
Challenges were performed with the O, Campos and A 
Venceslau strains of the FMDV, which are homologous to 
those used in the manufacturing of the vaccines, previously 
adapted to guinea pigs by two or more passages until lesions 
developed within 24 hours after inoculation into the hind 
footpads. Viral dilutions of 104 to 10 ® in phosphatebuffered 
saline (PBS, 0.5 M NaCl/0.01 M P 04  , pH 7.4-7.6) were used 
to inoculate the control group and dilutions of 10' to 10’ 
were used to inoculate the vaccinated group. Guinea pigs 
were then observed daily for seven days for the occurence of 
viral generalization. The infectious titre of the virus expressed 
as 50% infectious unit or dose (ITJ0), was calculated by the 
REED; MUENCH15 (1938) method and the specificity of these 
viral strains was determined by the complement fixation test 
according to the technique described by CAMARGO et al.1 
(1950).
C Index in guinea pigs (Cavia cavia)
The C Index (Cl) method for FMD vaccine testing of LUCAM 
et al.12 (1964) was used. A group of albino guinea pigs weigh­
ing 450 to 550 g was injected subcutaneously with 0.1 ml 
dose of vaccine to be tested, and an unvaccinated group was 
used as control. Twenty-one days after vaccination, the FMDV
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previously adapted to this species was inoculated into one of 
the hind footpads at the dose of 0.1 ml. Guinea pigs with no 
lesions or lesions only at the inoculation site were regarded as 
protected and those with more extensive lesions as unprotected. 
The quotient between the FMDV titres obtained for the control 
and vaccinated animals provided the Cl value.
Four guinea pigs per viral dilution were used to test the effect 
of number of guinea pigs on the variations in the results of 
the test, and five guinea pigs were used when an attempt was 
made to determine the minimum number of animals needed 
to reduce variation.
RESULTS AND DISCUSSION
The results of the test carried out to determine the efficiency 
of two vaccines against FMDV (vaccines I and II) and obtained 
by six replications of each vaccine (C Index test) using four 
animals per viral dilution are presented in Tab. 1. The indices 
calculated from the titres for control group A and for control 
group B and from the mean for the two groups (A and B) 
indicate the disparity of the results obtained. The C indices 
obtained varied statistically both when calculated from differ­
ent control groups as well as within the same control group.
The variations in the Cl results demonstrate that the quality 
of a vaccine being tested depends on chance when only one 
quality test is performed using a small number of guinea pigs.
TABLE 1
Results of the C Indices for guinea pigs, of vaccines I and II with six 
replications of the test, calculated from control groups A and B and 
from the mean (X) tor the two control groups inoculated with ~01" Campos 
of FMDV using four animals per viral dilution. Campinas - SP, 1990.
Vaccine I Vaccine II
Number 
of replie.
Vacc.
titre
•A Cl •BCI • x c i Vacc
titre
•A Cl •BCI •XCI
1 3.50 1.38 2.30 1.84 2.87 1 96 2 63 2.30
2 3.00 1 8 8 2.80 2.34 3.81 1 0 2 1.69 1.36
3 2.54 2.34 3.26 2.80 2.54 2 29 2.96 2.63
4 3.40 1.48 2.40 1.94 2.89 194 261 2.28
5 3.53 1.35 2.27 1.81 2.50 2.33 3.00 2.67
6 2.58 2.30 3 22 2.76 3.37 1.46 2.13 1.80
1Tm values obtained for control groups A: vaccine I, 4.88; vaccine II, 4.83 
ITk values obtained for control groups B: vaccine I, 5.80; vaccine II, 5.50 
IT^ obtained for control groups A and B : vaccine I, 5.34; vaccine H, 5.17 
Vacc. litre - IT^ of the vaccinated group
* A CI, B Cl and X Cl - C indices obtained from control groups A and B and 
from their mean, respectively
IT^- 50% infectious titre (infecting units) vims per ml log]t
On the basis of quality levels adopted by CUNHA et al.1 
(1957) in the Seroprotection Index for mice and of those 
detected by GOMES; ASTUDILLO10 (1975), the results for 
the two vaccines were transformed into “levels of vaccine 
quality” and classified as P (rejected poor) for vaccines which 
obtained a Cl of less than one (CI<1), R (rejected regular) for 
vaccines with a Cl greater or equal to one and less than two 
(1<CI<2), B (approved good) for vaccines with a Cl greater 
or equal to two and less than three (2<CI<3) and M (approved 
very good) for vaccines reaching a Cl value of three or greater 
(CI>3), as described in Tab. 2.
TABLE 2
Results of the quality levels of two lots of FMD vaccines (I and II) 
considering the levels starting from the C indices in guinea pigs, with 
six test replications, calculated from control groups A and B and from 
the means (X) for the two groups inoculated with strain ’O ,' Campos of 
FMDV. Campinas - SP. 1990
Number
of
replie.
Vaccine I Vaccine II
TA TB TX TA TB TX
1 R* G R R G G
2 R G G R R R
3 G V G G G G
4 R G R R G G
5 R G R B V B
6 G V G R G R
totals:
P 0 0 0 0 0 0
R 4 0 3 4 1 2
G 2 4 3 2 4 4
V 0 2 0 0 1 0
TA and TB - Values transformed from the C Indices obtained for control 
groups A and B, respectively
TX - Values transformed from the C Indices obtained from the mean of 
control groups A and B
* P = Poor (rejected vaccine)
R = Regular (rejected vaccine)
G = Good (approved vaccine)
V = Very good (approved vaccine)
These data indicate the wide variation that can occur when 
four guinea pigs are used per viral dilution for the calculation 
of the 50% infectious titre and of the respective C Indices, 
since the same vaccine can be classified as regular or good, 
good or very good and regular, good or very good depending 
on chance.
For this reason, an attempt was made to determine the smallest 
number of guinea pigs per viral dilution needed to obtain an 
acceptable maximum variation, such as that proposed by 
GONÇALVES" (1980), who demonstrated that at least 55 
suckling mice are needed per viral dilution for the variation 
in Mouse Protection Index to be approximately 0.5, with 95% 
confidence limits.
This maximum value of one (1) is fully justifiable since be­
cause of chance, the result obtained may fall within a classifi­
cation range for better or for worse, i.e., it may reach a maxi­
mum of two ranges. However, if a value higher than one is 
used, the result, owing to chance, my be included in as many 
as two ranges of classification for better or for worse, and 
may even reach three ranges, which would be an undesirable 
type of evaluation.
As demonstrated in the present experiment, the number of 
guinea pigs may be the decisive factor for the final result of 
the C Index test. Indeed, LUCAM et al.IJ (1964), when 
proposing the C Index test using seven guinea pigs per viral 
dilution, considered the variations detected to be statistically 
acceptable. Similarly, FÉDIDA’ (1971) detected the exist­
ence of a correlation, which considered highly significant, 
between the C Index and the K Index in cattle (correlation 
coefficient “r” = 0.67). The variation of the values agreed 
with those obtained in the present study, but were statistically 
discordant. However, EISSNER; BOHM 3 (1976) were unable
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to reduce the variation of the test by increasing the number of 
guinea pigs when they used a virus adapted to the guinea pig 
myocardium for challenge.
The literature about the number of guinea pigs used in the 
efficiency tests of FMD vaccincs is scarce, whereas studies 
carried out on cattle are available. The reduced number of 
cattle used in efficiency tests due to the high cost of the 
procedure leads to limitations of precision and sensitivity 
(FECHNER4, 1966; FEDIDA5, 1971; FERNANDEZ ct al.7. 
1972; FEDIDA et al.6, 1977; GARLAND ct al.9, 1977; 
FERNANDEZ et al.*, 1985). The International Epizootic Of­
fice (OIE) recommends that the efficiency tests of vaccines 
against FMD should be expressed with a 95% confidence 
limit and the percentage of protection should be al least 70% 
in cattle (FEDIDA et al.‘, 1977).
With respect to the determination of the smallest number of 
guinea pigs utilized in the C Index test with 95% confidcnce 
limits, it was demonstrated that the variation in C Index 
decreases with increasing number of animals for titration. 
Tab. 3 presents the titres (in log10) obtained for the control 
groups and for the vaccinated groups and the corresponding 
C Indices with their respective arithmetic mean, standard 
deviation, amplitude of variation and Pearson coefficient of 
variation (%).
TABLE 3
C Indices for guinea pigs, with six test replications, calculated from 
the vaccinated groups (vaccine III) and from the control group 
inoculated with the "A" Venceslau strain of FMDV, using five guinea 
pigs per viral dilution. Campinas - SP. 1990.
Number of 
replie.
’  control 
titre
vaccinated
titre
C Index
1 798 2.05 5.93
2 8.13 2.30 5.83
3 8.13 2.13 6 . 0 0
4 8  47 2  08 6  39
5 6  85 1 80 5.05
6 8.55 1 80 6  75
Arithm mean 8 . 0 2 2.03 5 99
Standard dev. 0.61 0  2 0 0 57
Amplit variat. 1.70 0.50 1.70
Coeffic variat.% 7.63 9.66 9.59
* - 50% infectious viral titre per ml in log10 for guinea pigs in the control and
vaccinated groups
Arithm. mean - Arithmetic mean
Standard dev. - Standard deviation
Amplit. variât. - Amplitude variation
Coeffic. variai. % - Coefficient variation %
The results obtained, when submitted to 2 by 2, 3 by 3, 4 by 4 
and 5 by 5 arrangements, covered all possible combinations 
representative of the values detected, as if 5, 10, 15, 20 and 
25 guinea pigs were used, respectively, and consequently all 
of these results correspond to 30 guinea pigs per viral dilution. 
The viral litre was 10*02 in the control group and 10203 in the 
vaccinated group, and the C Index value was 5.99.
Tab. 4 presents the values of the statistical parameters of the 
C Indices for the 1 by 1, 2 by 2, 3 by 3, 4 by 4, 5 by 5 and 6 
by 6 arrangements corresponding to six replications. As 
expectcd, the arithmetic mean of the C Indices was 5.99 in all
cases. The variation measured by the standard deviations and 
by the Pearson coefficient of variation (%), as well as the 
amplitude of variation decreased with increasing number of 
guinea pigs per viral dilution (corresponding to 1 ,2 , 3, 4, 5 
and 6 guinea pig groups).
TABLE 4
Values of the statistical parameters for the C Indices corresponding to 
all possible combinations in the six test replications Campinas SP. 
1990
Combination of the six test replications
1 by 1 2  by 2 3 by 3 4 by 4 5 by 5 6  by 6
N 6 15 2 0 15 6  1
Arithm mean 5 99 5 99 5.99 5 99 5 99 5.99
Standard dev 0.57 0 34 0 24 0.17 0 . 1 1  0  0 0
Amplit. variat. 1 70 1.13 078 0.57 0.34 0.00
Coeffic. variat. 9.59 5.73 0 . 0 2 2.89 0.19 000%
Arithm. mean • Arithmetic means 
Standard dev. - Standard deviation 
Amplit. variat. - Amplitude variation 
Cocffic. variat. - Coefficient variation 
N - Number of combinations
From deviations of plus or minus 2 (±2) standard deviations 
(initial proposition, a  equal to 0.05), it is possible to deter­
mine both graphically or by calculation the site where varia­
tion is one (1) logarithm. This point corresponded to the 2.91 
value. Since the objective was to find the number of animals, 
the number obtained was 14.55 (rounded to 15), meaning that 
15 guinea pigs per viral dilution are needed for titration to 
have a maximum variation in C Index of 1 ± 0.5 at the 95% 
level of probability.
RESUM O
Duas vacinas antiaftosa foram submetidas a seis repetições cada, 
à prova de eficiência, “índice C”, usando-se para titulação, 
quatro cobaias por diluição de vírus. Os valores encontrados, 
quando transformados em qualidade de vacina, demonstraram 
que uma mesma vacina poderia ser enquadrada como sendo 
“reprovada regular”, “aprovada boa” ou “aprovada muito boa”, 
indicando que a variação dos resultados, dependendo do caso, 
pode indefinir a classificação do imunógeno. Para verificar se 
tais variações são devidas ao pequeno número de cobaias, uma 
vacina foi submetida a seis repetições, usando-se cinco cobaias 
por diluição do vírus na prova “índice C”. Os arranjos 2 a 2, 3 
a 3, 4 a 4, 5 a 5, realizados a partir dos resultados correspon­
dentes a todas as combinações possíveis quando são usadas 5, 
10, 15, 20, 25 ou 30 cobaias por diluição viral, demonstraram 
que a variação de mais ou menos 0,5 logaritmo com 95% de 
segurança, corresponde a 15 cobaias.
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